Sandy Donaldson

Sandy Donaldson has an extensive work experience in various roles. In 2002, they began working at Avery Dennison Corporation as a Medical Device BD - Six Sigma. In 2008, they joined UCB and held the roles of Head of Global Omnichannel, Director - Head of Multichannel & Digital OE, Director - Operational Excellence Central Europe, Associate Director - Business Operations and CNS Sales Mgt, Associate Director - Project Financing & Integration, and Corporate Business Development and Licensing. In 2020, they became the CEO & Co-Founder of Impiricus, where they have redefined the interaction model between HCPs and pharma. In 2022, they became an Investor at Toucan (JoinToucan.com).

Sandy Donaldson has a comprehensive education history. In 1998, they began their studies at Glasgow Caledonian University, studying European Business Studies. In 2000, they completed a Diploma in International Business and Relations at Ecole Superieure de Paris Exterior. From 2007 to 2008, they completed an MBA in International Business at Vlerick Business School. In 2014, they finished an Executive Education in Leadership & Strategy in Pharmaceuticals & Biotechnology at Harvard Business School. Finally, in 2018, they completed a C-Suite Certificate in Change Management at Emory University.